Arturo S Mendoza1, Ho-Seong Han2, Yoo-Seok Yoon2, Jai Young Cho2, YoungRok Choi2. 1. Department of Surgery, University of Santo Tomas Hospital, Manila, Philippines. 2. Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 166 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 463-707, South Korea.
Abstract
BACKGROUND: Few reports have described laparoscopy-assisted pancreaticoduodenectomy (LAPD) as an alternative to the conventional open approach for periampullary tumors. The safety and feasibility of this procedure remain to be determined. In this study, we compared the short-term clinical outcomes of LAPD with those of open pancreaticoduodenectomy (OPD). METHODS: A retrospective review of patients who had undergone pancreaticoduodenectomy for periampullary tumors between June and December 2014 was conducted. Patient demographic data and their pathological and short-term clinical parameters were compared between the LAPD and OPD groups. RESULTS: Fifty-two patients were included in the study: 18 had undergone LAPD and 34 had undergone OPD. The mean operation time was longer for LAPD than for OPD (531.1 vs. 383.2 min, P < 0.001). The estimated blood loss, rate of blood transfusion, surgical resection margin status, and number of lymph nodes retrieved were similar in both groups. Overall morbidity and the incidence of pancreatic fistula did not differ significantly between the two groups. However, the mean length of hospital stay was significantly shorter in the LAPD group (12.6 vs. 18.6 days, P = 0.001). CONCLUSION: LAPD is a technically safe and feasible alternative treatment for periampullary tumors, with short-term clinical outcomes equivalent to those of OPD, with a shorter hospital stay.
BACKGROUND: Few reports have described laparoscopy-assisted pancreaticoduodenectomy (LAPD) as an alternative to the conventional open approach for periampullary tumors. The safety and feasibility of this procedure remain to be determined. In this study, we compared the short-term clinical outcomes of LAPD with those of open pancreaticoduodenectomy (OPD). METHODS: A retrospective review of patients who had undergone pancreaticoduodenectomy for periampullary tumors between June and December 2014 was conducted. Patient demographic data and their pathological and short-term clinical parameters were compared between the LAPD and OPD groups. RESULTS: Fifty-two patients were included in the study: 18 had undergone LAPD and 34 had undergone OPD. The mean operation time was longer for LAPD than for OPD (531.1 vs. 383.2 min, P < 0.001). The estimated blood loss, rate of blood transfusion, surgical resection margin status, and number of lymph nodes retrieved were similar in both groups. Overall morbidity and the incidence of pancreatic fistula did not differ significantly between the two groups. However, the mean length of hospital stay was significantly shorter in the LAPD group (12.6 vs. 18.6 days, P = 0.001). CONCLUSION: LAPD is a technically safe and feasible alternative treatment for periampullary tumors, with short-term clinical outcomes equivalent to those of OPD, with a shorter hospital stay.
Authors: Claudio Ricci; Riccardo Casadei; Giovanni Taffurelli; Carlo Alberto Pacilio; Marco Ricciardiello; Francesco Minni Journal: World J Surg Date: 2018-03 Impact factor: 3.352
Authors: M Thomaschewski; H Neeff; T Keck; H P H Neumann; T Strate; E von Dobschuetz Journal: Rev Endocr Metab Disord Date: 2017-12 Impact factor: 6.514
Authors: Matteo De Pastena; Jony van Hilst; Thijs de Rooij; Olivier R Busch; Michael F Gerhards; Sebastiaan Festen; Marc G Besselink Journal: J Vis Exp Date: 2018-06-17 Impact factor: 1.355
Authors: Harish Lavu; Neal S McCall; Jordan M Winter; Richard A Burkhart; Michael Pucci; Benjamin E Leiby; Theresa P Yeo; Shawnna Cannaday; Charles J Yeo Journal: J Am Coll Surg Date: 2019-01-17 Impact factor: 6.113
Authors: Michał Pędziwiatr; Piotr Małczak; Magdalena Pisarska; Piotr Major; Michał Wysocki; Tomasz Stefura; Andrzej Budzyński Journal: Langenbecks Arch Surg Date: 2017-05-09 Impact factor: 3.445
Authors: Michał Pędziwiatr; Piotr Małczak; Piotr Major; Jan Witowski; Beata Kuśnierz-Cabala; Piotr Ceranowicz; Andrzej Budzyński Journal: Med Oncol Date: 2017-06-01 Impact factor: 3.064